GlaxoSmithKline - GSK - global pharmaceutical company

GlaxoSmithKline

Do more, feel better, live longer

GSK worldwide



Fighting lymphatic filariasis

In 1998 GSK formed a partnership with the world health organisation to eliminate LF through the donation of its antiparasitic medicine, albendazole

More about our commitment to eliminate lymphatic filariasis

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Corporate press releases

[an error occurred while processing this directive] [an error occurred while processing this directive]

08 September 2010
GlaxoSmithKline and Genmab announce start of ofatumumab Phase III combination study in non-Hodgkin’s lymphoma

08 September 2010
GSK announces succession plan for Chief Financial Officer

08 September 2010
Galapagos reaches agreement to acquire GlaxoSmithKline research centre in Zagreb, Croatia

Press release archive


RSS Subscribe to press release RSS feed
What are RSS feeds?

Investors

LSE
1,266p
6.00

08 Sep 2010 04:49 pm BST
NYSE
39.10
0.19

08 Sep 2010 04:01 pm EDT
London Stock Exchange price updated every 15 minutes. Provided by Investis Limited.

Products

Prescription medicines


Vaccines


Consumer brands